Advertisement
Demo

Catalyst Pharma sees net price of drug, once free, topping $300,000

Feb 12, 2019 , Reuters
Catalyst Pharmaceuticals Inc said on Monday that it expects its drug for a rare disease, which had long been available to patients for free, will cost more than $300,000 per year including rebates to insurers and other discounts.


Read the full story...


Trending healthcare news keywords at this moment

drug costs world public heart experts hospital data obesity bills doctors hospitals ebola treatment cases measles swine fever alzheimer's brains brain warning labels scientists tip study deadly patients aha news stroke xifaxan state highlights viewpoints care medicaid lawmakers gun control water law digital research pain half states diabetes vaping cancer vaccine throat surgery young junel fe takes mental proposes approves disease air lung kids workers adults blood pressure risk affect legionnaires' outbreak people linked type fda tb graphic meds hadlima